3,688
edits
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
[https://pubmed.ncbi.nlm.nih.gov/11176085/ Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics] | [https://pubmed.ncbi.nlm.nih.gov/11176085/ Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics] | ||
[https://pubs.asahq.org/anesthesiology/article/136/6/985/136246/End-tidal-Anesthetic-Concentration-Monitoring End-tidal Anesthetic Concentration: Monitoring, Interpretation, and Clinical Application] | |||
[https://pubmed.ncbi.nlm.nih.gov/12401594/ Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease] | [https://pubmed.ncbi.nlm.nih.gov/12401594/ Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease] |